Literature DB >> 26808569

Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.

M Brown1, D Myers2, N Shreve2, R Rahmetullah2, M Radhi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26808569     DOI： 10.1038/bmt.2015.333

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.

Authors:  Renata Bizzetto; Carmen Bonfim; Vanderson Rocha; Gérard Socié; Franco Locatelli; Kawah Chan; Oscar Ramirez; Joel Stein; Samir Nabhan; Eliana Miranda; Jakob Passweg; Carmino Antonio de Souza; Eliane Gluckman
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

2.  Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita.

Authors:  L G Vuong; P G Hemmati; S Neuburger; T H Terwey; T Vulliamy; I Dokal; P le Coutre; B Dörken; R Arnold
Journal:  Acta Haematol       Date:  2010-11-02       Impact factor: 2.195

3.  Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita.

Authors:  Nobuhiro Nishio; Yoshiyuki Takahashi; Haruhiko Ohashi; Sayoko Doisaki; Hideki Muramatsu; Asahito Hama; Akira Shimada; Hiroshi Yagasaki; Seiji Kojima
Journal:  Pediatr Transplant       Date:  2010-12-22

4.  Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experience.

Authors:  P H Shaw; P R Haut; M Olszewski; M Kletzel
Journal:  Pediatr Transplant       Date:  1999-11

5.  Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimen.

Authors:  Mattia Algeri; Patrizia Comoli; Luisa Strocchio; Cesare Perotti; Franco Corbella; Claudia Del Fante; Ambrogia Baio; Giovanna Giorgiani; Antonella Gurrado; Elisa Accornero; Chiara Cugno; Andrea Pession; Marco Zecca
Journal:  J Pediatr Hematol Oncol       Date:  2015-05       Impact factor: 1.289

6.  Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.

Authors:  Bari J Ballew; Meredith Yeager; Kevin Jacobs; Neelam Giri; Joseph Boland; Laurie Burdett; Blanche P Alter; Sharon A Savage
Journal:  Hum Genet       Date:  2013-01-18       Impact factor: 4.132

Review 7.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

8.  Dyskeratosis Congenita (DC) Registry: identification of new features of DC.

Authors:  S Knight; T Vulliamy; A Copplestone; E Gluckman; P Mason; I Dokal
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

9.  Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.

Authors:  Josu de la Fuente; Inderjeet Dokal
Journal:  Pediatr Transplant       Date:  2007-09

10.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

Authors:  Shahinaz M Gadalla; Carmem Sales-Bonfim; Jeanette Carreras; Blanche P Alter; Joseph H Antin; Mouhab Ayas; Prasad Bodhi; Jeffrey Davis; Stella M Davies; Eric Deconinck; H Joachim Deeg; Reggie E Duerst; Anders Fasth; Ardeshir Ghavamzadeh; Neelam Giri; Frederick D Goldman; E Anders Kolb; Robert Krance; Joanne Kurtzberg; Wing H Leung; Alok Srivastava; Reuven Or; Carol M Richman; Philip S Rosenberg; Jose Sanchez de Toledo Codina; Shalini Shenoy; Gerard Socié; Jakub Tolar; Kirsten M Williams; Mary Eapen; Sharon A Savage
Journal:  Biol Blood Marrow Transplant       Date:  2013-06-08       Impact factor: 5.742
View more
  1 in total

Review 1.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.

Authors:  Andrew C Dietz; Parinda A Mehta; Adrianna Vlachos; Sharon A Savage; Dorine Bresters; Jakub Tolar; Farid Boulad; Jean Hugues Dalle; Carmem Bonfim; Josu de la Fuente; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-20       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.